Yes the trial itself was a failure only due to design delivering a false negative. They tried to recruit more participants to give the statistics more power and make them more reliable but clearly not enough. The problem I have with cometary here is people trying to portray Viraleze itself as a failure. It is far from that. Read the comments from the scientific community involved in the study. Very impressed and positive feedback.
Yes the trial itself was a failure only due to design delivering...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 394540 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 57000 | 3 |
View Market Depth
| Last trade - 11.15am 13/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |
Day chart unavailable